Search results
Results From The WOW.Com Content Network
The diagnosis of branch retinal vein occlusion is made clinically by finding retinal hemorrhages in the distribution of an obstructed retinal vein. Fluorescein angiography is a helpful adjunct. Findings include delayed venous filling, hypofluorescence caused by hemorrhage and capillary nonperfusion, dilation and tortuosity of veins, leakage due ...
Since the central retinal artery and vein are the sole source of blood supply and drainage for the retina, such occlusion can lead to severe damage to the retina and blindness, due to ischemia (restriction in blood supply) and edema (swelling). [2] CRVO can cause ocular ischemic syndrome. Nonischemic CRVO is the milder form of the disease.
Central retinal artery occlusion: CRAO is characterized by painless, acute vision loss in one eye. [11] Central retinal vein occlusion: CRVO causes sudden, painless vision loss that can be mild to severe. [12] Branch retinal vein occlusion: sudden painless vision loss or visual field defect are the main symptom of BRVO. [13]
IRMA can be difficult to distinguish from and is likely a precursor to retinal neovascularization. One way to distinguish IRMA from retinal neovascularization is to perform fluorescein angiography. Since IRMA blood vessels are patent, unlike neovascular vessels, they do not leak, and therefore exhibit hyperfluorescence on fluorescein angiography.
The central retinal vein (retinal vein) is a vein that drains the retina of the eye. It travels backwards through the centre of the optic nerve accompanied by the central retinal artery before exiting the optic nerve together with the central retinal artery to drain into either the superior ophthalmic vein or the cavernous sinus .
Retinal hemorrhage is strongly associated with child abuse in infants and young children [3] and often leaves such abused infants permanently blind. In older children and adults, retinal hemorrhage can be caused by several medical conditions such as hypertension, retinal vein occlusion (a blockage of a retinal vein), anemia, leukemia or diabetes.
Other conditions causing rubeosis iridis include central retinal vein occlusion, [2] ocular ischemic syndrome, [3] and chronic retinal detachment. Pathophysiology
A 2014 Cochrane Systematic Review studied the effectiveness of ranibizumab and pegaptanib, on patients who have macular edema caused by central retinal vein occlusion. [5] Participants in both treatment groups showed improvement in visual acuity measures and a reduction in macular edema symptoms over six months.